Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra Indust | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 12.94B | 22x | 1.04 | SAR 161.80 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.1% Upside | Upgrade to Pro+ | |
Jamjoom Pharmaceuticals Factory | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 10.84B | 31.4x | 1.42 | SAR 159 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
Saudi chemical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 7.13B | 21.7x | 0.12 | SAR 8.45 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SPIMACO | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 3.31B | 99.1x | 1.09 | SAR 27.70 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.8% Upside | Upgrade to Pro+ | |
Middle East Pharmaceutical | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 2.61B | 33.3x | 0.35 | SAR 127.20 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.4% Downside | Upgrade to Pro+ | |
Qomel | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 412.30M | 15.7x | 0.17 | SAR 112.80 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Almujtama Alraida Medical Co SJSC | Saudi Arabia | Healthcare | Pharmaceuticals | SAR 275.50M | 26.2x | SAR 29.50 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |